The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Surface Oncology, Inc(NASDAQ:SURF) 
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 (IgG4) monoclonal antibody for the production of extracellular a...
Website: http://www.surfaceoncology.com
Founded: 2014
Full Time Employees: 49
Sector: Healthcare
Industry: Biotechnology
Surface Oncology Days Receivable Outstanding ttm (DSO)
Surface Oncology Op Cashflow Per Share ttm
Surface Oncology Free Cashflow Per Share ttm
Surface Oncology Cash Per Share ttm
Surface Oncology P/S ratio ttm
Surface Oncology (GAAP) P/E ratio ttm
Surface Oncology P/B ratio ttm
No extra charts and metrics for this ticker.